These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Gjerstad MD; Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP Neurology; 2006 Sep; 67(5):853-8. PubMed ID: 16966550 [TBL] [Abstract][Full Text] [Related]
23. Excessive daytime sleepiness in parkinsonism. Arnulf I Sleep Med Rev; 2005 Jun; 9(3):185-200. PubMed ID: 15893249 [TBL] [Abstract][Full Text] [Related]
24. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. Hobson DE; Lang AE; Martin WR; Razmy A; Rivest J; Fleming J JAMA; 2002 Jan 23-30; 287(4):455-63. PubMed ID: 11798367 [TBL] [Abstract][Full Text] [Related]
25. Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study. Vignatelli L; Bisulli F; Naldi I; Ferioli S; Pittau F; Provini F; Plazzi G; Vetrugno R; Montagna P; Tinuper P Epilepsia; 2006; 47 Suppl 5():73-7. PubMed ID: 17239111 [TBL] [Abstract][Full Text] [Related]
26. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease. Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399 [TBL] [Abstract][Full Text] [Related]
27. Dopamine agonists and sleepiness in PD: review of the literature and personal findings. Manni R; Terzaghi M; Sartori I; Mancini F; Pacchetti C Sleep Med; 2004 Mar; 5(2):189-93. PubMed ID: 15033142 [TBL] [Abstract][Full Text] [Related]
28. Levodopa-induced sleepiness in the Parkinson variant of multiple system atrophy. Seppi K; Högl B; Diem A; Peralta C; Wenning GK; Poewe W Mov Disord; 2006 Aug; 21(8):1281-3. PubMed ID: 16639726 [TBL] [Abstract][Full Text] [Related]
29. Excessive daytime sleepiness and on-road driving performance in patients with Parkinson's disease. Amick MM; D'Abreu A; Moro-de-Casillas ML; Chou KL; Ott BR J Neurol Sci; 2007 Jan; 252(1):13-5. PubMed ID: 17109893 [TBL] [Abstract][Full Text] [Related]
30. Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study. Monaca C; Duhamel A; Jacquesson JM; Ozsancak C; Destée A; Guieu JD; Defebvre L; Derambure P Sleep Med; 2006 Aug; 7(5):448-53. PubMed ID: 16740409 [TBL] [Abstract][Full Text] [Related]
31. Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleep. Havlikova E; van Dijk JP; Rosenberger J; Nagyova I; Middel B; Dubayova T; Gdovinova Z; Groothoff JW J Neurol Sci; 2008 Jul; 270(1-2):107-13. PubMed ID: 18371981 [TBL] [Abstract][Full Text] [Related]
32. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease. Dusek P; Busková J; Růzicka E; Majerová V; Srp A; Jech R; Roth J; Sonka K Clin Neuropharmacol; 2010 Jul; 33(4):186-90. PubMed ID: 20661025 [TBL] [Abstract][Full Text] [Related]
33. Patients cured from craniopharyngioma or nonfunctioning pituitary macroadenoma (NFMA) suffer similarly from increased daytime somnolence despite normal sleep patterns compared to healthy controls. van der Klaauw AA; Biermasz NR; Pereira AM; van Kralingen KW; Dekkers OM; Rabe KF; Smit JW; Romijn JA Clin Endocrinol (Oxf); 2008 Nov; 69(5):769-74. PubMed ID: 18435832 [TBL] [Abstract][Full Text] [Related]
35. The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Mulgrew AT; Ryan CF; Fleetham JA; Cheema R; Fox N; Koehoorn M; Fitzgerald JM; Marra C; Ayas NT Sleep Med; 2007 Dec; 9(1):42-53. PubMed ID: 17825611 [TBL] [Abstract][Full Text] [Related]
36. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset. Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066 [TBL] [Abstract][Full Text] [Related]
37. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Kaynak D; Kiziltan G; Kaynak H; Benbir G; Uysal O Eur J Neurol; 2005 Mar; 12(3):199-207. PubMed ID: 15693809 [TBL] [Abstract][Full Text] [Related]
38. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
39. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder. Ozekmekçi S; Apaydin H; Kiliç E Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389 [TBL] [Abstract][Full Text] [Related]